PyInvesting

Market research

ISRG Intuitive Surgical Inc

NASDAQ USD Healthcare

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market cap
136B
P/E ratio
43.49
Analyst target
478.0093
Dividend yield
Not available
Beta
1.46

Community

Investor discussion

8 comments

Admin profile picture
Admin

5 years, 4 months ago

Intuitive Surgical, Inc is currently in a long term uptrend where the price is trading 21.1% above its 200 day moving average.

From a valuation standpoint, the stock is 98.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 20.6.

Intuitive Surgical, Inc's total revenue rose by 4.0% to $1B since the same quarter in the previous year.

Its net income has increased by 3.6% to $371M since the same quarter in the previous year.

Finally, its free cash flow fell by 30.4% to $286M since the same quarter in the previous year.

Based on the above factors, Intuitive Surgical, Inc gets an overall score of 4/5.

New Guy profile picture
New Guy

5 years, 7 months ago

$TRXC Compared to $ISRG.... TECH IS BETTER. CLEAR VISION FOR 2021 with Japan and Russia on board. They are already applying for FDA usage of their next model...... FUCKING BULLISH
Nebnosam profile picture
Nebnosam

5 years, 7 months ago

$ISRG 90 PE, it‘s tulip bulb season again.
Linda Krehbiel profile picture
Linda Krehbiel

5 years, 7 months ago

$PLUG when you are a leader in a respective “virgin”industry you have a competitive edge to gain huge market share by entrenching your footprints long before others. That was the success of $ISRG and they remain a pure standalone since they developed their robotic surgical machines long before anyone was considering the idea. With plug, you at the same time have your market expanded overseas into a new continent, and you have a Biden agenda. That’s called a trifecta. Look at the stock success of $ISRG. I expect nothing less over the next decade with Plug Power. Don’t sell. GLTA
HailMary profile picture
HailMary

5 years, 7 months ago

$TRXC no way this randomly jumped above 75% in just one day. This is not even on robinhood's list of top 100 buys so we can factor out emotional newbies from there. No news I founded to mark today. IMO then the good news here is it could be a sudden increase of new buyers coming into the market for 2021 start after finishing their DDs. If they are convicted like me, they will share TP of $5 by end of 2021 based on pure momentum. TRXC is a great underdog story with 2021 their year to graduate and at least tick closer to $ISRG $800 share price. Hold on for ride up to $5!!
“Gl” profile picture
“Gl”

5 years, 7 months ago

@Sluggn NKLA has been trading at a multi billion $ market cap for months even though the company is a fraud. If you think $TRXC has valuation problems you are crazy. The pandemic is pushing robotic surgery through the roof. You are wrong to be short this one it is too dangerous. My take is you have been burned with this stock and are bitter, happened to a friend of mine in $NIO , he bought at $12 and then sold at $5, when NIO was at a $1 I told him I was going to buy some, he was so bitter and burnt he just bashed the stock in a million ways and missed out on a 50 bagger. I think you will see $TRXC trade at much higher prices. Don’t be a fool and don’t be stubborn, we know you are not shorting a $1 stock, you are just butthurt. $ISRG
George Ponderevo profile picture
George Ponderevo

5 years, 7 months ago

This chart says so much. $ISRG 1. Setting new 52wk highs while growth/tech corrected? Bullish. 2. Money flow is VERY strong. Bullish. 3. Chart implies that surgeries will NOT be delayed. Hospitals have backlogs for years. 4. Two-month price target = 880 5. Own this stock, don't swing it.
HailMary profile picture
HailMary

5 years, 8 months ago

$TRXC is a market competitor to $ISRG which is currently $807/share. They are a competitor because they actually have a product with customers. Yes, there are medical tech giants in active development but for the next 3 years IMO it's just $TRXC and $ISRG - the price gap is too extreme not to close up. $TRXC is cheaper and they target secondary and third markets. If Russia starts buying this for their state-sponsored hospitals then this will shoot up to $50/share. That is my TP for next 3-year hold. Please tell me how I am wrong. I want to learn to balance out my thoughts. Thanks!